Ekso Bionics Holdings Inc
Change company Symbol lookup
Select an option...
EKSO Ekso Bionics Holdings Inc
NOBL ProShares S&P 500 Dividend Aristocrats ETF
NLY Annaly Capital Management Inc
NGG National Grid PLC
NEM Newmont Corporation
NDP Tortoise Energy Independence Fund, Inc
NCV AllianzGI Convertible & Income Fund
NCV AllianzGI Convertible & Income Fund
NAC Nuveen California Quality Municipal Income Fund
MUC BlackRock MuniHoldings California Quality Fund, Inc.
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.

Closing Price
$2.76
Day's Change
-0.07 (-2.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.91
Day's Low
2.60
Volume
(Light)
Volume:
112,978

10-day average volume:
160,004
112,978

Display:

Providers:

UpdateCancel
7 providers
March 24, 2020
Ekso Bionics(R) Announces Reverse Stock Split

Ekso Bionics Holdings, Inc. (the "Company") (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that it will effect a reverse stock split of shares of its common stock at a ratio of 1-for-15...(Globe Newswire)

February 27, 2020
Ekso Bionics Reports Fourth Quarter and Year End 2019 Results

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2019. (Globe Newswire)

February 25, 2020
Ekso Bionics(R) Announces Collaboration with Kindred Healthcare to Pilot EksoNR in Long-Term Acute Care Hospitals

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collaboration with Kindred Healthcare, LLC ("Kindred") to pilot EksoNR-- the most clinically used robotic exoskeleton...(Globe Newswire)

February 20, 2020
Ekso Bionics(R) to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2019 after the close...(Globe Newswire)

February 19, 2020
Post Acute Medical (PAM) Accelerates Adoption of Exoskeleton Rehabilitation with Three Additional EksoNR Devices from Ekso Bionics(R)

Post Acute Medical, LLC, (PAM), a system of inpatient rehabilitation hospitals, has acquired three additional EksoNR devices from Ekso Bionics (Nasdaq: EKSO) to expand the availability of exoskeleton-assisted rehabilitation to seven of its...(Globe Newswire)

February 12, 2020
Rehabilitation Robots Market Size worth USD 2,617.3 Million by 2026 | Industry Size, Share, Trends, Growth, Forecast Report

The global Rehabilitation Robots Market size is projected to reach USD 2,617.3 million by 2026, registering an impressive CAGR of 22.1% during the forecast period. Increasing number of disabled and aged people around the world will primarily the...(Globe Newswire)

February 06, 2020
Ekso Bionics(R) Releases its Upgraded EksoPulse Platform, Advanced Cloud-Based Analytics for Robotic Exoskeleton-Assisted Rehabilitation

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a leading developer of robotic exoskeletons, today announced the worldwide launch of its upgraded EksoPulse platform, an innovative cloud-based information technology platform that measures and analyzes...(Globe Newswire)

January 10, 2020
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2019 Financial Results; Company Achieves Record Fourth Quarter Revenue

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2019. (Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.